• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Elevated level of cell-free plasma DNA is associated with advanced-stage breast cancer and metastasis.

作者信息

Nicolini Carmela, Ens Cíntia, Cerutti Talita, Roehe Adriana Vial, Agnes Grasiela, Damin Andréa P S, Alexandre Cláudio O P

出版信息

Clin Chem Lab Med. 2013 Jun 27;51(11):e277-8. doi: 10.1515/cclm-2013-0120.

DOI:10.1515/cclm-2013-0120
PMID:23807672
Abstract
摘要

相似文献

1
Elevated level of cell-free plasma DNA is associated with advanced-stage breast cancer and metastasis.游离血浆DNA水平升高与晚期乳腺癌及转移相关。
Clin Chem Lab Med. 2013 Jun 27;51(11):e277-8. doi: 10.1515/cclm-2013-0120.
2
Concordance of Hypermethylated DNA and the Tumor Markers CA 15-3, CEA, and TPA in Serum during Monitoring of Patients with Advanced Breast Cancer.晚期乳腺癌患者监测期间血清中DNA高甲基化与肿瘤标志物CA 15-3、癌胚抗原和组织多肽抗原的一致性
Biomed Res Int. 2015;2015:986024. doi: 10.1155/2015/986024. Epub 2015 Aug 3.
3
Plasma prolactin as an indicator of disease progression in advanced breast cancer.血浆催乳素作为晚期乳腺癌疾病进展的指标。
Cancer. 1990 May 1;65(9):2028-32. doi: 10.1002/1097-0142(19900501)65:9<2028::aid-cncr2820650924>3.0.co;2-9.
4
[Decreased plasma zinc levels in metastatic breast cancer].转移性乳腺癌患者血浆锌水平降低
Onkologie. 1990 Jun;13(3):207-9. doi: 10.1159/000216760.
5
Elevated level of cell-free plasma DNA is associated with breast cancer.游离血浆DNA水平升高与乳腺癌相关。
Arch Gynecol Obstet. 2007 Oct;276(4):327-31. doi: 10.1007/s00404-007-0345-1. Epub 2007 Mar 13.
6
Is the TNM staging system for breast cancer still relevant in the era of biomarkers and emerging personalized medicine for breast cancer - an institution's 10-year experience.在生物标志物和乳腺癌新兴个性化医疗时代，乳腺癌的TNM分期系统是否仍然适用——一家机构的10年经验
Breast J. 2015 Mar-Apr;21(2):147-54. doi: 10.1111/tbj.12367. Epub 2015 Jan 20.
7
Quantification of free circulating tumor DNA as a diagnostic marker for breast cancer.游离循环肿瘤DNA的定量分析作为乳腺癌的诊断标志物
DNA Cell Biol. 2008 Aug;27(8):415-21. doi: 10.1089/dna.2008.0744.
8
Circulating tumor DNA in early-stage breast cancer: personalized biomarkers for occult metastatic disease and risk of relapse?早期乳腺癌中的循环肿瘤DNA：隐匿性转移性疾病和复发风险的个性化生物标志物？
EMBO Mol Med. 2015 Aug;7(8):994-5. doi: 10.15252/emmm.201505332.
9
Identification of E545k mutation in plasma from a PIK3CA wild-type metastatic breast cancer patient by array-based digital polymerase chain reaction: Circulating-free DNA a powerful tool for biomarker testing in advance disease.通过基于芯片的数字聚合酶链反应鉴定PIK3CA野生型转移性乳腺癌患者血浆中的E545k突变：游离循环DNA是晚期疾病生物标志物检测的有力工具。
Transl Res. 2015 Dec;166(6):783-7. doi: 10.1016/j.trsl.2015.04.010. Epub 2015 Apr 27.
10
Elevated Levels of Serum Tumor Markers CEA and CA15-3 Are Prognostic Parameters for Different Molecular Subtypes of Breast Cancer.血清肿瘤标志物癌胚抗原（CEA）和糖类抗原15-3（CA15-3）水平升高是乳腺癌不同分子亚型的预后参数。
PLoS One. 2015 Jul 24;10(7):e0133830. doi: 10.1371/journal.pone.0133830. eCollection 2015.

引用本文的文献

1
Circulating Cell-Free DNA in Breast Cancer: Searching for Hidden Information towards Precision Medicine.乳腺癌中的循环游离DNA：探寻精准医学的隐藏信息
Cancers (Basel). 2021 Feb 10;13(4):728. doi: 10.3390/cancers13040728.
2
Non-Invasive Biomarkers for Early Detection of Breast Cancer.用于乳腺癌早期检测的非侵入性生物标志物
Cancers (Basel). 2020 Sep 27;12(10):2767. doi: 10.3390/cancers12102767.
3
Review of the clinical applications and technological advances of circulating tumor DNA in cancer monitoring.循环肿瘤DNA在癌症监测中的临床应用及技术进展综述
Ther Clin Risk Manag. 2017 Oct 11;13:1363-1374. doi: 10.2147/TCRM.S141991. eCollection 2017.
4
Value of circulating cell-free DNA analysis as a diagnostic tool for breast cancer: a meta-analysis.循环游离DNA分析作为乳腺癌诊断工具的价值：一项荟萃分析
Oncotarget. 2017 Apr 18;8(16):26625-26636. doi: 10.18632/oncotarget.15775.
5
The impact of chronic kidney disease and short-term treatment with rosiglitazone on plasma cell-free DNA levels.慢性肾脏病及罗格列酮短期治疗对血浆无细胞游离 DNA 水平的影响。
PPAR Res. 2014;2014:643189. doi: 10.1155/2014/643189. Epub 2014 Oct 13.
6
The clinical utilization of circulating cell free DNA (CCFDNA) in blood of cancer patients.循环游离 DNA（CCFDNA）在癌症患者血液中的临床应用。
Int J Mol Sci. 2013 Sep 13;14(9):18925-58. doi: 10.3390/ijms140918925.